This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thackray, A. M.
Right arrow Articles by Field, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thackray, A. M.
Right arrow Articles by Field, H. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2000, p. 97-102, Vol. 44, No. 1
0066-4804/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy

Alana M. Thackray and Hugh J. Field*

Centre for Veterinary Science, Cambridge University Veterinary School, Cambridge CB3 0ES, United Kingdom

Received 21 June 1999/Returned for modification 27 August 1999/Accepted 20 September 1999

Young adult mice were inoculated with herpes simplex virus type 2 (HSV-2) in the ear pinna. A relatively severe infection resulted, and 45% of the mice died by 11 days postinfection. Therapy at 1 mg/ml by means of the drinking water with either famciclovir for periods of 5 or 10 days or valaciclovir for 5, 10, 15, or 20 days decreased clinical signs and reduced mortality to 15% or less. Throughout a period of 27 days, mice were tested daily for the presence of infectious virus in the ear pinna, brain stem, and ipsilateral trigeminal ganglia. Virus was cleared from these tissues in surviving, untreated animals by 12 days postinfection, and no infectious virus was detected subsequently in any tissue. Furthermore, no infectious virus was detected after day 9 in mice that had been treated with famciclovir. In mice that had received valaciclovir therapy, however, infectious virus was repeatedly detected in the trigeminal ganglia and brain stem tissue samples up to 7 days after treatment was discontinued. To date, no specific mechanism to account for these results has been discovered; however, possible mechanisms for the persistence of potentially infectious virus in neural tissue of treated mice are discussed.


* Corresponding author. Mailing address: Centre for Veterinary Science, Cambridge University Veterinary School, Madingley Rd., Cambridge CB3 0ES, United Kingdom. Phone: (44) 01223 330810. Fax: (44) 01223 332998. E-mail: hjf10{at}cam.ac.uk.


Antimicrobial Agents and Chemotherapy, January 2000, p. 97-102, Vol. 44, No. 1
0066-4804/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Loutsch, J. M., Sainz, B. Jr., Marquart, M. E., Zheng, X., Kesavan, P., Higaki, S., Hill, J. M., Tal-Singer, R. (2001). Effect of Famciclovir on Herpes Simplex Virus Type 1 Corneal Disease and Establishment of Latency in Rabbits. Antimicrob. Agents Chemother. 45: 2044-2053 [Abstract] [Full Text]  
  • Thackray, A. M., Field, H. J. (2000). The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment. J. Gen. Virol. 81: 2385-2396 [Abstract] [Full Text]